Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PT Kimia Farma Persero Tbk's quarterly market cap
declined
from Dec. 2025 (Rp2,866,793 Mil) to Mar. 2026 (Rp2,571,764 Mil) and
declined
from Mar. 2026 (Rp2,571,764 Mil) to Jun. 2026 (Rp2,337,967 Mil).
PT Kimia Farma Persero Tbk's annual market cap
declined
from Dec. 2023 (Rp8,025,530 Mil) to Dec. 2024 (Rp3,367,784 Mil) and
declined
from Dec. 2024 (Rp3,367,784 Mil) to Dec. 2025 (Rp2,866,793 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PT Kimia Farma Persero Tbk's Enterprise Value for Today is Rp10,112,250 Mil.
PT Kimia Farma Persero Tbk (ISX:KAEF) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PT Kimia Farma Persero Tbk Market Cap Related Terms
PT Kimia Farma Persero Tbk Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, PT Kimia Farma Persero Tbk's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Kimia Farma Persero Tbk Market Cap vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Kimia Farma Persero Tbk's Market Cap distribution charts can be found below:
* The bar in red indicates where PT Kimia Farma Persero Tbk's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Kimia Farma Persero Tbk (ISX:KAEF) has a Market Cap of Rp2,449,299 Mil as of Aug. 16, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Kimia Farma Persero Tbk and its competitors. According to the industry distribution chart, PT Kimia Farma Persero Tbk ranks #60 out of 122 companies in the Medical Distribution industry, placing it in the top 49.2%.
Is PT Kimia Farma Persero Tbk's Market Cap too high?
PT Kimia Farma Persero Tbk's current Market Cap is Rp2,449,299 Mil. Based on the distribution chart, PT Kimia Farma Persero Tbk ranks #60 out of 122 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, PT Kimia Farma Persero Tbk has a GF Score™ of 55/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PT Kimia Farma Persero Tbk's Market Cap compare to MCK and COR?
According to the Medical Distribution industry distribution chart, PT Kimia Farma Persero Tbk ranks #60 out of 122 companies for Market Cap. This puts PT Kimia Farma Persero Tbk in the upper half of its industry. The industry median Market Cap is 133.11. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Distribution company?
The median Market Cap among Medical Distribution companies is 133.11, based on 122 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PT Kimia Farma Persero Tbk and its competitors. For the Medical Distribution industry, the median Market Cap is 133.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Kimia Farma Persero Tbk's current Market Cap is Rp2,449,299 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Kimia Farma Persero Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk (ISX:KAEF) is currently considered Modestly Undervalued. The stock's GF Value™ is Rp579.89, compared to a current price of Rp440.00 — trading 24.1% below its estimated fair value. The current Market Cap is Rp2,449,299 Mil. PT Kimia Farma Persero Tbk's overall GF Score™ is 55/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PT Kimia Farma Persero Tbk (ISX:KAEF), the current Market Cap is Rp2,449,299 Mil as of Aug. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Kimia Farma Persero Tbk (ISX:KAEF) Overvalued in 2026?
Based on GuruFocus' analysis, PT Kimia Farma Persero Tbk stock appears to be undervalued.
The current stock price of Rp440.00 is trading 24.1% below its estimated GF Value™ of Rp579.89.
GuruFocus considers PT Kimia Farma Persero Tbk to be Modestly Undervalued.
Key valuation signals for ISX:KAEF:
Market Cap: Rp2,449,299 Mil
GF Value™: Rp579.89 vs. price of Rp440.00 (24.1% below fair value)
No single metric tells the full story. See the ISX:KAEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Kimia Farma Tbk is an Indonesia-based company engaged in the production and distribution of healthcare products. It operates through the following segments: Manufacture, Distribution, Retail, and Others. The company provides its products in categories including OTC & Herb, Ethical, Cosmetic, Generic, and others. Some of its product offerings include Alergine, Kimoxil, Loprezol, Enkasari, and Batugin among others. It generates maximum revenue from the Retail segment.
55GF Score
Get the complete analysis for ISX:KAEF
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:KAEF has been successfully added to your 
